PT — Normal Range & Interpretation

Clinical Context

Prothrombin time measures how long plasma takes to clot after tissue factor is added, reflecting the extrinsic and common coagulation pathways (factors I, II, V, VII, and X). Clinicians track PT alongside the INR to monitor warfarin therapy, assess hepatic synthetic function, and screen for bleeding risk before invasive procedures. The INR standardizes PT results across laboratories and guides warfarin dosing decisions.

PT prolongs with warfarin use, vitamin K deficiency, liver disease, disseminated intravascular coagulation, and factor VII deficiency. Antibiotics that disrupt gut flora reduce vitamin K synthesis and extend PT. Diets high in leafy greens shorten PT and blunt warfarin effect. Shortened PT carries limited clinical significance but appears with supplemental vitamin K intake or specimen handling errors.

FNPs see PT on the boards most often in the context of warfarin management, including target INR ranges of 2 to 3 for most indications and 2.5 to 3.5 for mechanical mitral valves. Expect questions linking elevated PT to hepatic failure, reversal of warfarin with vitamin K or fresh frozen plasma, and drug-food interactions that alter anticoagulation. Candidates must distinguish PT from aPTT, which monitors heparin and the intrinsic pathway, and recognize when to hold warfarin before surgery.

Related Labs

• INR
• aPTT — seconds
• D-dimer — μg/mL

Sources

• MedlinePlus
• ARUP Consult